RESPREEZA 4000 mg, powder and solvent for solution for injection/infusion bottle, 76 ml
Active ingredients: ALPHA-1 ANTITRYPSINE HUMAINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injection and infusionbottle, 76 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RESPREEZA 4000 mg, poudre et solvant pour solution injectable/perfusion
- Pharmaceutical form
- poudre et solvant pour solution injectable et pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 4000 mg -1 flacon en verre de 76 ml avec dispositif de transfert 20/20 (dispositif Mix2Vial)
- Marketing authorisation holder
- CSL BEHRING (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Aug 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64642836CIP75505701CIP133400955057017Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALPHA-1 ANTITRYPSINE HUMAINEpoudre | 4000 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.